Hypothesis and Theory

Published on 29 Nov 2022

Vemurafenib inhibits immune escape biomarker BCL2A1 by targeting PI3K/AKT signaling pathway to suppress breast cancer

in Cancer Molecular Targets and Therapeutics

Yalan Dai
Liqiong Yang
Abass Sakandar
Duoli Zhang
Fukuan Du
Xinyi Zhang
Linglin Zou
Yueshui Zhao
Jigang Wang
Zhenhua Zhang

Frontiers in Oncology

doi 10.3389/fonc.2022.906197

2,587 views
2 citations

Original Research

Published on 25 Nov 2022

KIAA1429 regulates alternative splicing events of cancer-related genes in hepatocellular carcinoma

in Cancer Molecular Targets and Therapeutics

Zhao-chen Liu
Lu-Hao Li
Ding-Yang Li
Zhi-Qiang Gao
Dong Chen
Bin Song
Bing-Hua Jiang
Xiao-wei Dang

Frontiers in Oncology

doi 10.3389/fonc.2022.1060574

2,851 views
6 citations

Editorial

Published on 25 Nov 2022

Editorial: Megakaryocytes as regulators of tumor microenvironments

in Cancer Molecular Targets and Therapeutics

Anna Rita Migliaccio
Alessandra Balduini
Huichun Zhan

Frontiers in Oncology

doi 10.3389/fonc.2022.1090658

1,073 views
1 citation

Original Research

Published on 25 Nov 2022

The pro-invasive factor COL6A2 serves as a novel prognostic marker of glioma

in Cancer Molecular Targets and Therapeutics

Jinchao Zhu
Qingyuan Lin
Haiyan Zheng
Yamin Rao
Tianhai Ji

Frontiers in Oncology

doi 10.3389/fonc.2022.897042

4,386 views
7 citations

Original Research

Published on 24 Nov 2022

Pan-cancer analysis reveals DDX21 as a potential biomarker for the prognosis of multiple tumor types

in Cancer Molecular Targets and Therapeutics

Ankang Hu
Yonghui Wang
Jiahao Tian
Zihan Chen
Renjin Chen
Xufeng Han
Yang Chen
Tingjun Liu
Quangang Chen

Frontiers in Oncology

doi 10.3389/fonc.2022.947054

4,864 views
9 citations

Review

Published on 24 Nov 2022

Circ_0007534 as new emerging target in cancer: Biological functions and molecular interactions

in Cancer Molecular Targets and Therapeutics

Bowen Liu
Chengbin Dong
Quan Chen
Zhenhua Fan
Yu Zhang
Yifan Wu
Ting Cui
Fuquan Liu

Frontiers in Oncology

doi 10.3389/fonc.2022.1031802

1,777 views
1 citation

Case Report

Published on 24 Nov 2022

NSCLC patients with rare EGFR Ex19del/G724S mutation showed good response to afatinib combined with chemotherapy treatment: A two-case report

in Cancer Molecular Targets and Therapeutics

Huilin Wang
Qitao Yu
Lina Shi
Qinhan Hou
Liang Dan
Chuqiao Liang
Xiaoyu Hong
Yun Zhao
Ruiling Ning

Frontiers in Oncology

doi 10.3389/fonc.2022.1054593

2,269 views
1 citation

Case Report

Published on 24 Nov 2022

Efficacy of dabrafenib/trametinib in pancreatic ductal adenocarcinoma with BRAF NVTAP deletion: A case report

in Cancer Molecular Targets and Therapeutics

Ji Eun Shin
Ho Jung An
Hyung Soon Park
Hyunho Kim
Byoung Yong Shim

Frontiers in Oncology

doi 10.3389/fonc.2022.976450

2,702 views
6 citations

Correction

Published on 23 Nov 2022

Corrigendum: CDKN2A determines mesothelioma cell fate to EZH2 inhibition

in Cancer Molecular Targets and Therapeutics

Giulia Pinton
Zhuo Wang
Cecilia Balzano
Sara Missaglia
Daniela Tavian
Renzo Boldorini
Dean A. Fennell
Martin Griffin
Laura Moro

Frontiers in Oncology

doi 10.3389/fonc.2022.1081632

1,384 views

Original Research

Published on 23 Nov 2022

The efficacy and safety of Apatinib in the treatment of advanced non-small cell lung cancer: A retrospective trial

in Cancer Molecular Targets and Therapeutics

Jijin Wang
Di Huang
Wenjing Yang
Qingxu Song
Yibin Jia
Pengxiang Chen
Yufeng Cheng

Frontiers in Oncology

doi 10.3389/fonc.2022.1030798

1,292 views
1 citation

Original Research

Published on 23 Nov 2022

ZNF24 regulates the progression of KRAS mutant lung adenocarcinoma by promoting SLC7A5 translation

in Cancer Molecular Targets and Therapeutics

Daqi Jia
Leilei Li
Peng Wang
Qiang Feng
Xinyan Pan
Peng Lin
Shuling Song
Lilin Yang
Julun Yang

Frontiers in Oncology

doi 10.3389/fonc.2022.1043177

2,013 views
2 citations

Systematic Review

Published on 21 Nov 2022

Prognostic significance of CDC20 expression in malignancy patients: A meta-analysis

in Cancer Molecular Targets and Therapeutics

Feng Xian
Xuegang Yang
Guohui Xu

Frontiers in Oncology

doi 10.3389/fonc.2022.1017864

2,183 views
3 citations

Original Research

Published on 18 Nov 2022

Patient-derived xenograft models for gastrointestinal tumors: A single-center retrospective study

in Cancer Molecular Targets and Therapeutics

Xiongfei Yu
Yiran Chen
Jun Lu
Kuifeng He
Yanyan Chen
Yongfeng Ding
Ketao Jin
Haiyong Wang
Haibin Zhang
Haohao Wang

Frontiers in Oncology

doi 10.3389/fonc.2022.985154

2,831 views
5 citations

Original Research

Published on 18 Nov 2022

Comparison of general anesthesia and continuous intravenous sedation for electrochemotherapy of head and neck skin lesions

in Cancer Molecular Targets and Therapeutics

Janez Benedik
Barbara Ogorevc
Simona Kranjc Brezar
Maja Cemazar
Gregor Sersa
Ales Groselj

Frontiers in Oncology

doi 10.3389/fonc.2022.1011721

1,751 views
3 citations

Original Research

Published on 17 Nov 2022

β-(4-fluorobenzyl) Arteannuin B induced interaction of ATF-4 and C/EBPβ mediates the transition of breast cancer cells from autophagy to senescence

in Cancer Molecular Targets and Therapeutics

Khalid Bashir Mir
Mir Mohd Faheem
Syed Mudabir Ahmad
Javeed Ur Rasool
Tanzeeba Amin
Souneek Chakraborty
Madhulika Bhagat
Zabeer Ahmed
Asif Ali
Anindya Goswami

Frontiers in Oncology

doi 10.3389/fonc.2022.1013500

3,030 views
7 citations

Review

Published on 17 Nov 2022

Utilization of macrocyclic peptides to target protein-protein interactions in cancer

in Cancer Molecular Targets and Therapeutics

Jiawen Yang
Qiaoliang Zhu
Yifan Wu
Xiaojuan Qu
Haixia Liu
Biao Jiang
Di Ge
Xiaoling Song

Frontiers in Oncology

doi 10.3389/fonc.2022.992171

5,699 views
6 citations

Navigation group

Articles

Vemurafenib inhibits immune escape biomarker BCL2A1 by targeting PI3K/AKT signaling pathway to suppress breast cancer

KIAA1429 regulates alternative splicing events of cancer-related genes in hepatocellular carcinoma

Editorial: Megakaryocytes as regulators of tumor microenvironments

The pro-invasive factor COL6A2 serves as a novel prognostic marker of glioma

Pan-cancer analysis reveals DDX21 as a potential biomarker for the prognosis of multiple tumor types

Circ_0007534 as new emerging target in cancer: Biological functions and molecular interactions

NSCLC patients with rare EGFR Ex19del/G724S mutation showed good response to afatinib combined with chemotherapy treatment: A two-case report

Efficacy of dabrafenib/trametinib in pancreatic ductal adenocarcinoma with BRAF NVTAP deletion: A case report

Corrigendum: CDKN2A determines mesothelioma cell fate to EZH2 inhibition

The efficacy and safety of Apatinib in the treatment of advanced non-small cell lung cancer: A retrospective trial

ZNF24 regulates the progression of KRAS mutant lung adenocarcinoma by promoting SLC7A5 translation

Prognostic significance of CDC20 expression in malignancy patients: A meta-analysis

Patient-derived xenograft models for gastrointestinal tumors: A single-center retrospective study

Comparison of general anesthesia and continuous intravenous sedation for electrochemotherapy of head and neck skin lesions

β-(4-fluorobenzyl) Arteannuin B induced interaction of ATF-4 and C/EBPβ mediates the transition of breast cancer cells from autophagy to senescence

Utilization of macrocyclic peptides to target protein-protein interactions in cancer